Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Beetroot juice may help stave off memory loss, small study hints

NCT ID NCT07329647

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether drinking beetroot juice daily for two weeks can improve memory and brain blood flow in 25 people with small vessel disease and diabetes. The juice is rich in nitrate, which the body can convert to nitric oxide, a molecule that helps blood vessels widen. Researchers will compare the effects of nitrate-rich beetroot juice against a placebo juice that has the nitrate removed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
beetroot juice (dietary nitrate)
What this could lead to
If it works, this could point toward a simple dietary supplement to help slow memory loss in people with small vessel disease.
What could go wrong
This is a very small pilot study with only 25 participants, so results may not apply widely. The treatment is short-term (2 weeks), and any benefits might be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Formal diagnosis of cerebral small vessel disease (grades 1 to 3 in the Age-Related White Matter Changes Scale as assessed by Computerized Tomography or Magnetic Ressonance Imaging - MRI) and patients at high risk for cerebral small vessel disease with diabetes mellitus; * Subject has capacity and is capable of giving written informed consent; * Subject is able to read, comprehend and record information written in Portuguese. Exclusion Criteria: * Vascular diseases other than cerebral Small Vessel Disease (cSVD); * Stroke event less than 6 months ago; * Unsuitable for MRI scanning because of presence of any standard MRI contraindication (e.g presence of a cardiac pacemaker, other medical implants or devices, or the presence of ferromagnetic metal foreign bodies); * Needle phobia; * Inability or intolerance to dietary polyphenol adjustment; * Current smoker; * Alcohol abuse, drug abuse or use of drugs affecting cognitive assessment, such as sedatives, hypnotics, nootropic drugs, cholinergic drugs; * Use of medications that may be contraindicated or interact with the high nitrate diet, such as nitroglycerin or nitrate preparations used for angina, or phosphodiesterase type 5 (PDE5) inhibitors, including sildenafil (Viagral); * Patients previously diagnosed with dementia; * Presence of congenital mental retardation and severe neurological and psychiatric diseases; * Illiterate or severe visual or hearing impairment that may prevent patients from cooperating with cognitive assessment; * Relevant depression or other unrelated serious mental illness; * Severe cardiac, pulmonary, renal or hepatic insufficiency; * Patients who have participated in other interventional clinical studies within the last 3 months, or are participating in other interventional clinical studies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases cerebrovascular disorder diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institute for Nuclear Sciences Applied to Health (ICNAS), University of Coimbra

    RECRUITING

    Coimbra, Portugal

  • Unidade de Saúde Local de Coimbra (ULS Coimbra)

    RECRUITING

    Coimbra, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.